IL6DX - Overview: Interleukin-6, Serum
Evaluating patients with suspected chronic inflammatory disorders, such as rheumatoid arthritis, systemic lupus erythematosus, ankylosing spondylitis, or inflammatory bowel disease Evaluating patients with Castleman disease Evaluating...
IGAS - Overview: IgA Subclasses, Serum
Investigation of immune deficiency due to IgA2 deficiency Evaluating patients with anaphylactic transfusion reactions
GAL1 - Overview: GALAD Score, Serum
Calculation of the GALAD (gender, age, alpha-fetoprotein L3% [AFP-L3], AFP, des-gamma-carboxy prothrombin) model score for hepatocellular carcinoma development in patients with chronic liver disease
LAGGT - Overview: Granulocyte Antibodies, Serum
Work-up of individuals having febrile, nonhemolytic transfusion reactions Detection of individuals with autoimmune neutropenia This test is not useful for the diagnosis of neutropenia caused by marrow suppression by drugs or tumors.
GENTA - Overview: Gentamicin, Trough, Serum
Monitoring adequacy of drug clearance during gentamicin therapy
UE3 - Overview: Estriol, Unconjugated, Serum
As an adjunct biomarker in the prenatal diagnosis of disorders of fetal steroid metabolism, including Smith-Lemli-Opitz syndrome (1,2) and X-linked ichthyosis (placental sulfatase deficiency disorders) Evaluating primary or secondary fetal...
FIBRO - Overview: FibroTest-ActiTest, Serum
Evaluating hepatic fibrosis in chronic hepatitis C patients Diagnosing fibrosis in carriers of chronic hepatitis B virus Evaluating hepatic fibrosis in co-infected HIV carriers Providing access to new-generation non-interferon...
GAL3 - Overview: Galectin-3, Serum
Aiding in the prognosis for patients diagnosed with heart failure Risk stratification of patients with heart failure An early indication of treatment failure and as a therapeutic target
GENPA - Overview: Gentamicin, Peak, Serum
Monitoring adequacy of drug clearance during gentamicin therapy
LEPDT - Overview: Leptospira, IgM, Serum
Aiding in the diagnosis of leptospirosis This test is not useful for establishing cure or response to therapy.
IGGS - Overview: IgG Subclasses, Serum
Second-order testing for evaluation of patients with clinical signs and symptoms of humoral immunodeficiency or combined immunodeficiency (cellular and humoral)
INAB - Overview: Insulin Antibodies, Serum
Predicting the future development of type 1 diabetes in asymptomatic children, adolescents, and young adults, when used in conjunction with family history, human leukocyte antigen-typing, and other autoantibodies, including glutamic acid...
LIVPR - Overview: Liver Profile, Serum
Screening for liver damage, especially if someone has a condition or is taking a drug that may affect the liver
APOA1 - Overview: Apolipoprotein A1, Serum
Evaluating risk for atherosclerotic cardiovascular disease Aiding in the detection of Tangier disease
ABADL - Overview: Adalimumab Antibody, Serum
Therapeutic drug monitoring of adalimumab antibody levels
QNADL - Overview: Adalimumab Quantitative, Serum
Therapeutic drug monitoring of adalimumab concentration
APOLB - Overview: Apolipoprotein B, Serum
Assessment of cardiovascular risk Follow-up studies in individuals with basic lipid measures inconsistent with risk factors or clinical presentation Definitive studies of cardiac risk factors in individuals with significant family...
BILID - Overview: Bilirubin Direct, Serum
Evaluation of jaundice and liver functions
C3 - Overview: Complement C3, Serum
Assessing disease activity in systemic lupus erythematosus Investigating an undetectable total complement level
PNYA - Overview: Phenytoin, Total, Serum
Monitoring for appropriate therapeutic concentration Assessing compliance or toxicity
PRMB - Overview: Primidone and Phenobarbital, Serum
Assessing compliance Monitoring for appropriate therapeutic levels of primidone and phenobarbital Assessing toxicity
PNYF - Overview: Phenytoin, Free, Serum
Monitoring for appropriate therapeutic concentration of free phenytoin: free phenytoin level is the best indicator of adequate therapy in renal failure Assessing compliance and toxicity
MEPHS - Overview: Mephobarbital and Phenobarbital, Serum
Monitoring of mephobarbital and phenobarbital therapy
TGAB - Overview: Thyroglobulin Antibody, Serum
As an adjunct in the diagnosis of autoimmune thyroid diseases: Hashimoto disease, postpartum thyroiditis, neonatal hypothyroidism, and Graves disease
TPO - Overview: Thyroperoxidase Antibodies, Serum
Aiding in the diagnosis of thyroid autoimmune disorders Differentiating thyroid autoimmune disorders from nonautoimmune goiter or hypothyroidism As a diagnostic tool in deciding whether to treat a patient who has subclinical...
CHOL - Overview: Cholesterol, Total, Serum
Evaluation of cardiovascular risk
C1Q - Overview: Complement C1q, Serum
Assessment of an undetectable total complement level Diagnosing congenital C1 (first component of complement) deficiency Diagnosing acquired deficiency of C1 inhibitor
CDP - Overview: Chlordiazepoxide and Metabolite, Serum
Monitoring chlordiazepoxide therapy Assessing toxicity
CORTF - Overview: Cortisol, Free, Serum
Assessment of cortisol status in cases where there is known or a suspected abnormality in cortisol-binding proteins or albumin Assessment of adrenal function in the critically ill or stressed patient, thus preventing unnecessary use of...
DIA - Overview: Diazepam and Nordiazepam, Serum
Assessing compliance Monitoring for appropriate therapeutic level Assessing diazepam toxicity
DHEA_ - Overview: Dehydroepiandrosterone (DHEA), Serum
Diagnosing and differential diagnosis of hyperandrogenism (in conjunction with measurements of other sex steroids) As an initial screen in adults with bioavailable testosterone measurement that may be supplemented with measurements of sex...
TRIGC - Overview: Triglycerides, CDC, Serum
Measurement of triglycerides as part of lipoprotein profiling
VANTA - Overview: Vancomycin, Trough, Serum
Preferred test for monitoring vancomycin therapy Monitoring trough concentrations drawn at steady-state in selected patients receiving vancomycin therapy
PEAN - Overview: Peanut, IgE, Serum
Establishing a diagnosis of an allergy to peanut Defining the allergen responsible for eliciting signs and symptoms Identifying allergens: -Responsible for allergic response and/or anaphylactic episode -To confirm sensitization prior to...
MDNS - Overview: Methadone and Metabolites, Serum
Compliance monitoring of methadone Assessment of methadone toxicity
VANRA - Overview: Vancomycin, Random, Serum
Monitoring adequacy of drug concentration during vancomycin therapy whenever a specimen is submitted or collected without collection timing information
COM - Overview: Complement, Total, Serum
Detection of individuals with an ongoing immune process First-tier screening test for congenital complement deficiencies
ETGL - Overview: Ethylene Glycol, Serum
Confirming and monitoring ethylene glycol toxicity
ELPSR - Overview: Electrolyte Panel, Serum
Identifying a suspected imbalance in electrolytes or acid/base imbalance
HEVML - Overview: Hepatitis E Virus IgM Antibody Confirmation, Serum
Confirmation of reactive hepatitis E virus IgM antibody screening test results for the diagnosis of acute or recent (<6 months) hepatitis E infection
HEVM - Overview: Hepatitis E Virus IgM Antibody Screen with Reflex to Confirmation, Serum
Diagnosis of acute or recent (<6 months) hepatitis E infection
TXM - Overview: Toxoplasma gondii Antibody, IgM, Serum
Detecting recent infection with Toxoplasma gondii
INSEC - Overview: Stinging Insects Allergen Profile, Serum
Establishing a diagnosis of an allergy to honeybee, yellow jacket, wasp, yellow faced hornet, and white-faced hornet venoms Defining the allergen responsible for eliciting signs and symptoms Identifying allergens: -Responsible for...
CMVG - Overview: Cytomegalovirus (CMV) Antibodies, IgG, Serum
Determining whether a patient (especially transplant recipients and organ and blood donors) has had a recent infection or previous exposure to cytomegalovirus
EMA - Overview: Endomysial Antibodies, IgA, Serum
Analysis of IgA-endomysial antibodies for the diagnosis of dermatitis herpetiformis and celiac disease Monitoring adherence to gluten-free diet in patients with dermatitis herpetiformis and celiac disease
NSIP - Overview: Non-Seasonal Inhalant Allergen Profile, Serum
Establishing a diagnosis of an allergy to non-seasonal inhalant allergen profile Defining the allergen responsible for eliciting signs and symptoms Identifying allergens: -Responsible for allergic response and/or anaphylactic episode -To...
C2 - Overview: C2 Complement, Functional, with Reflex, Serum
Investigation of a patient with a low (absent) hemolytic complement, with reflex testing to C3 and C4, if appropriate
EMAIG - Overview: Endomysial Antibodies, IgG, Serum
Analysis of IgG-endomysial antibodies for the diagnosis of dermatitis herpetiformis and celiac disease Monitoring adherence to gluten-free diet in patients with dermatitis herpetiformis and celiac disease
MTXSG - Overview: Methotrexate Post Glucarpidase, Serum
Monitoring methotrexate concentrations post-glucarpidase therapy Documenting failure to respond that may be due to noncompliance Guiding dosage adjustments in patients with kidney failure
RCVBS - Overview: Recoverin-IgG Antibody, Immunoblot, Serum
Evaluating patients with suspected paraneoplastic retinopathy accompanying small cell carcinoma
sequential-maternal-serum-screening-testing-algorithm.pdf
Foundation for Medical Education and Research (MFMER). All rights reserved. Sequential Maternal Serum Screening Testing Algorithm Diagnostic testing should be offered Screen-positive: results reported...
MCL Platelet Antibody Screen Serum Information MC1235242
MCL Platelet Antibody Screen Serum Information Complete print Platelet Antibody Screen Serum Patient Information Reset Form Patient Information Patient Middle Birth Date...
Mayo Clinic Laboratory and Pathology Research Roundup: Nov. 26 - Insights
This week’s Research Roundup highlights the effect of inorganic nitrite versus a placebo on exercise capacity among patients with heart failure with preserved ejection fraction....
Gravis/Lambert-Eaton Myasthenic Syndrome Evaluation, Serum
Confirming the autoimmune basis of a defect in neuromuscular transmission (eg, myasthenia gravis [MG], Lambert-Eaton myasthenic syndrome [LEMS]) Distinguishing LEMS from autoimmune forms of MG Providing a quantitative autoantibody...
Atypical Hemolytic Uremic Syndrome Complement Panel, Serum and Plasma
Detecting deficiencies in the alternative pathway that can cause atypical-hemolytic uremic syndrome, dense deposit disease, and C3 glomerulonephritis A second-tier test that aids in the differential diagnosis of thrombotic...